Financial Ratios

MOREPEN LABORATORIES LTD.

NSE : MOREPENLABBSE : 500288ISIN CODE : INE083A01026Industry : Pharmaceuticals & DrugsHouse : Morepen
BSE61.200.23 (+0.38 %)
PREV CLOSE ( ) 60.97
OPEN PRICE ( ) 61.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 758896
TODAY'S LOW / HIGH ( )60.62 62.85
52 WK LOW / HIGH ( )33.44 65.07
NSE61.220.26 (+0.43 %)
PREV CLOSE( ) 60.96
OPEN PRICE ( ) 61.64
BID PRICE (QTY) 61.22 (101717)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7959902
TODAY'S LOW / HIGH( ) 60.56 62.90
52 WK LOW / HIGH ( )33.05 65.12
Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)1.852.170.902.122.10
   CEPS(Rs)2.302.601.262.562.72
   DPS(Rs)0.200.000.000.000.00
   Book NAV/Share(Rs)21.5617.3915.2611.978.92
   Tax Rate(%)26.1725.5326.6519.500.00
Margin Ratios
   Core EBITDA Margin(%)9.8710.525.778.9110.10
   EBIT Margin(%)9.319.924.868.838.63
   Pre Tax Margin(%)8.859.694.718.668.47
   PAT Margin (%)6.537.213.456.978.47
   Cash Profit Margin (%)8.118.644.808.4411.00
Performance Ratios
   ROA(%)6.779.304.3210.7512.49
   ROE(%)9.8113.296.8420.7726.61
   ROCE(%)13.2917.719.1523.7324.54
   Asset Turnover(x)1.041.291.251.541.47
   Sales/Fixed Asset(x)2.763.112.702.911.92
   Working Capital/Sales(x)2.413.143.045.299.50
Efficiency Ratios
   Fixed Capital/Sales(x)0.360.320.370.340.52
   Receivable days71.6967.9365.0747.5245.43
   Inventory Days59.4751.2264.0153.8849.56
   Payable days118.9696.9392.6981.1292.58
Valuation Parameters
   PER(x)25.8119.3828.3917.3015.34
   PCE(x)20.8116.1820.4314.3011.82
   Price/Book(x)2.222.421.683.063.60
   Yield(%)0.420.000.000.000.00
   EV/Net Sales(x)1.711.380.961.191.26
   EV/Core EBITDA(x)15.6912.2015.4411.5411.25
   EV/EBIT(x)18.3513.9519.7113.4514.54
   EV/CE(x)2.112.321.591.671.65
   M Cap / Sales1.691.400.981.211.30
Growth Ratio
   Net Sales Growth(%)1.1014.84-7.6230.2840.46
   Core EBITDA Growth(%)-3.01110.03-44.3420.1568.03
   EBIT Growth(%)-5.11134.51-49.1933.25143.44
   PAT Growth(%)-8.44139.90-54.247.23191.49
   EPS Growth(%)-14.59139.90-57.230.94191.51
Financial Stability Ratios
   Total Debt/Equity(x)0.070.030.030.030.04
   Current Ratio(x)2.402.392.511.681.31
   Quick Ratio(x)1.781.771.791.040.86
   Interest Cover(x)20.3743.4532.8352.7553.71
   Total Debt/Mcap(x)0.030.010.020.010.01

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.